Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999

Gabapentin-Induced Anorgasmia
Neurol 53:2209, Clark,J.D.&Elliott,J., 1999

Effectiveness of Anticholinergics and Neuroleptic Dose Reduction on Neuroleptic-Induced Pleurothotonus (the Pisa Syndrome)
J Clin Psychopharmacol 19:277-280, Suzuki,T.,et al, 1999

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Bell's Palsy and HSV-1 Infection
Muscle & Nerve 22:1476-1478, Marra,C.M., 1999

Edema Associated with Calcified Lesions in Neurocysticercosis
Neurol 53:777-781, Nash,T.E.&Patronas,N.J., 1999

Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999

MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999

The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999

Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999

Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Dementia Following Treatment of Brain Tumors with Radiotherapy Administered Alone or in Combination with Nitrosourea-Based Chemotherapy: A Clinical and Pathological Study
J Neurooncol 41:137-149, Vigliani,M.C.,et al, 1999

Evaluation of Metronidazole Toxicity: A Prospective Study
Int J Clin Pharmacol Res 19:83-88, Kapoor,K.,et al, 1999

Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999

Hypoxic/Ischaemic Brain Damages, Especially Pallidal Lesions, in Heroin Addicts
Forensic Sci Int 102:51-59, Andersen,S.N. &Skullerud,K., 1999

Early Diagnosis of Central Nervous System Aspergillosis With Combination Use of Cerebral Diffusion-Weighted Echo-Planar Magnetic Resonance Image and Polymerase Chain Reaction of Cerebrospinal Fluid
Internal Medicine 38:45-48, Kami,M.,et al, 1999

Treatment of Postural Hypotension
JNNP 65:285-289, Mathias,C.J.&Kimber,J.R., 1998

Neurologic Emergencies in Cancer Patients
Neurol Clin 16:1-37, Schiff,D.,et al, 1998

Drug-Induced Movement Disorders
Neurol Clin 16:125-139, Diederich,N.J. & Goetz,C.G., 1998

Managemnt of Increased Intracranial Pressure
The Neurologist 4:2-12, Mayer,S.A. & Dennis,L.J., 1998

Rapid Diagnosis of Varicella Zoster Virus Infection in Acute Facial Palsy
Neurol 51:1202-1205, Murakami,S.,et al, 1998

Dystonia and Chorea in Acquired Systemic Disorders
JNNP 65:436-445, Janavs,J.L.&Aminoff,M.J., 1998

Lipodystrophy Associated with an HIV-Protease Inhibitor
NEJM 339:1296, Carr,A.&Cooper,D.A., 1998

Buffalo Hump in a Patient with the Acquired Immunodeficiency Syndrome
NEJM 339:1297, Aboulafia,D.M.&Bundow,D., 1998

Central Nervous System Infection with Listeria Monocytogenes
Medicine 77:313-316, Mylonakis,E.,et al, 1998

Influence of Human Immunodeficiency Virus 1 Infection and Degree of Immunosuppression in the Clinical Characteristics and Outcome of Infective Endocarditis in Intravenous Drug Users
Arch Int Med 158:2043-2050, Ribera,E.,et al, 1998

Clinicopath Conf,Sarcoidosis,with Involvement of Spinal Cord,Brain,Mediastinal Lymph Nodes and ? Lung,Case 35-1998
NEJM 339:1534-1541, , 1998

Use of the Polymerase Chain Reaction in the Diagnosis of Herpes Simplex Encephalitis:A Decision Analysis Model
Am J Med 105:287-295, Tebas,P.,et al, 1998

Neuroimaging Findings in Late Infantile GM1 Gangliosidosis
AJNR 19:1628-1630, Chen,C-Y.,et al, 1998

Distal Sensory Axonopathy after Sarin Intoxication
Neurol 51:1195-1197, Himuro,K.,et al, 1998

A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998

Pertussis Encephalopathy with High Cerebrospinal Fluid Antibody Titers to Pertussis Toxin and Filamentous Hemagglutinin
Pediatrics 102:986-990, Grant,C.C.,et al, 1998

Randomised Double-Blind Placebo-Controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II)
Lancet 352:1245-1251,1238, Hacke,W.,et al, 1998

Thrombolysis with Intravenous rtPA in a Series of 100 Cases of Acute Carotid Territory Stroke,Determination of Etiological,Topographic,and Radiological Outcome Factors
Stroke 29:2529-2540, Trouillas,P.,et al, 1998

Alteplase Not Yet Proven for Acute Ischaemic Stroke
Lancet 352:1238-1239,1245, Bath,P., 1998

Interferon B Therapy for Multiple Sclerosis
Lancet 352:1486-1487, Goodkin,D.E., 1998

Interferons in the Treatment of Multiple Sclerosis,Do They Prevent the Progression of the Disease?
Arch Neurol 55:1578-1580,1583, Rice,G.&Ebers,G, 1998

Interferons Should be Used to Treat Most Patients with MS
Arch Neurol 55:1581-1583, Herndon,R.M.&Jacobs,L, 1998

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998

Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
Ann Int Med 129:597-604, Gurwitz,J.H.,et al, 1998

Stroke Patterns of Internal Carotid Artery Dissection in 40 Patients
Stroke 29:2646-2648, Lucas,C.,et al, 1998

The Risk of Parkinson's Disease with Exposure to Pesticides, Farming, Well Water, and Rural Living
Neurol 50:1346-1350, Gorell,J.M.,et al, 1998

Olanzapine Can Worsen Parkinsonism
Neurol 50:1183-1184, Jimenez-Jimenez,F.J.,et al, 1998

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 50:1195-1196, Wolters,E.C.,et al, 1998

Myelopathy Caused by Nitrous Oxide Toxicity
AJNR 19:894-896, 9941998., Pema,P.J.,et al, 1998

Morality in DATATOP:A Multicenter Trial in Early Parkinson's Disease
Parkinson Study Group, Ann Neurol 43:318-3251998., , 1998